Company Overview

Update
Founded:
1986
Headquarters:
Ontario Center
IPO:
Went Public on Mar 5, 2004
Stock:
LRUSF
Categories:
Biotechnology
Description:
Lorus Therapeutics Inc. is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class

Detailed Description

Update

Lorus Therapeutics Inc. is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.

Current Team (3)

Update

Funding Rounds (1) - $28.3M

Update

Offices/Locations (1)

Update
  • Office

    2 Meridian Road

    Toronto,

    Ontario Center, M9W 4Z7

    CAN

News (2)

Update
  • SEC

    04/24/14 -sec.gov

Images (1)

Update
  • Cd4cfb52d323db264f1f6dcd3c4e32a5